CD274 and non-small cell lung carcinoma: According to the 2021 NCCN Clinical Practice Guidelines for Non-Small Cell Lung Cancer (NSCLC) (15), which stratifies treatment for patients with advanced NSCLC at initial diagnosis, genetic testing and PD-L1 expression analysis should be performed.